Category: Corporate NewsBy adminMay 17, 2022 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Rameda Reports its 1Q22 ResultsNextNext post:Disclosure to EGX regarding molecule acquisitionRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025Rameda One-Pager 1Q25May 13, 2025Earnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024
